Table 1.
Clinical parameters | Molecular subtypes (n, %) | p value | FDR | ||
---|---|---|---|---|---|
C1 | C2 | C3 | |||
Age | |||||
<60 | 99 | 121 | 22 | 0.3902838 | 0.4878548 |
≥60 | 116 | 138 | 16 | ||
T stage | |||||
T1-2 | 119 | 180 | 29 | 0.0015863 | 0.0044308 |
T3-4 | 96 | 79 | 9 | ||
Race | |||||
White | 194 | 234 | 25 | 0.0002154 | 0.0010770 |
Asian | 4 | 2 | 2 | ||
Black or African American | 17 | 23 | 11 | ||
Stage | |||||
Stage I | 87 | 147 | 22 | 0.0017723 | 0.0044308 |
Stage II | 24 | 26 | 6 | ||
Stage III | 62 | 54 | 2 | ||
Stage IV | 42 | 32 | 8 | ||
Radiation | |||||
Yes | 2 | 3 | 0 | 0.7913667 | 0.7913667 |
NO | 213 | 256 | 38 | ||
Pharmaceutical | |||||
Yes | 32 | 34 | 7 | 0.644558 | 0.7161756 |
NO | 183 | 225 | 31 | ||
Grade | |||||
G1 | 2 | 8 | 1 | < 0.0001 | < 0.0001 |
G2 | 77 | 129 | 13 | ||
G3 | 81 | 108 | 14 | ||
G4 | 54 | 14 | 5 | ||
GX | 1 | 0 | 5 | ||
Smoking | |||||
1-year | 106 | 131 | 28 | 0.1266751 | 0.2111252 |
2-year | 13 | 9 | 3 | ||
3-year | 80 | 97 | 6 | ||
4-year | 11 | 14 | 1 | ||
5-year | 5 | 8 | 0 | ||
Gender | |||||
FEMALE | 51 | 112 | 13 | 4.90E-05 | 0.0004796 |
MALE | 164 | 147 | 25 | ||
N | |||||
N0 | 91 | 115 | 22 | 0.03698 | 0.0739600 |
N1 | 11 | 3 | 2 | ||
NX | 113 | 141 | 14 | ||
M | |||||
M0 | 163 | 215 | 28 | 0.1552 | 0.2217143 |
M1 | 41 | 30 | 7 | ||
MX | 11 | 14 | 3 |